TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a

Xavier Palomer1, David Alvarez-Guardia, Ricardo Rodríguez-Calvo

  • 1Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, IBUB and CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)-Instituto de Salud Carlos III, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain.

Cardiovascular Research
|November 29, 2008
PubMed

Insights

Tumor necrosis factor-alpha (TNF-alpha) reduces cardiac peroxisome proliferator-activated receptor coactivator 1alpha (PGC-1alpha) expression, impacting myocardial metabolism. This downregulation may contribute to heart failure in inflammatory metabolic conditions.

Area of Science:

  • Cardiovascular Biology
  • Molecular Metabolism
  • Inflammation Research

Background:

  • Cytokine-driven inflammation is linked to cardiac hypertrophy and heart failure.
  • Myocardial metabolism dysregulation is increasingly associated with cardiomyopathy.
  • Tumor necrosis factor-alpha (TNF-alpha) is a key pro-inflammatory cytokine implicated in cardiac pathology.

Purpose of the Study:

  • To investigate the relationship between pro-inflammatory signaling and cardiac metabolic dysfunction.
  • To determine the effect of TNF-alpha on key metabolic regulators in cardiac cells.
  • To elucidate the molecular mechanisms linking inflammation to altered cardiac metabolism.

Main Methods:

  • Treatment of human cardiac AC16 cells with TNF-alpha.
  • Analysis of peroxisome proliferator-activated receptor coactivator 1alpha (PGC-1alpha) expression.
  • Studies in cardiac-specific transgenic mice overexpressing TNF-alpha.
  • Investigation of signaling pathways including p38 MAPK and NF-kappaB.
  • Assessment of glucose oxidation rates and key metabolic gene expression.

Main Results:

  • TNF-alpha inhibited PGC-1alpha expression in AC16 cells and in the hearts of TNF-alpha transgenic mice.
  • The inhibitory effect of TNF-alpha on PGC-1alpha was mediated by p38 MAPK and NF-kappaB pathways.
  • PGC-1alpha downregulation led to increased glucose oxidation via reduced pyruvate dehydrogenase kinase 4 expression.
  • This metabolic shift was dependent on PPAR beta/delta and ERR alpha transcription factors.

Conclusions:

  • Downregulation of PGC-1alpha by TNF-alpha is a significant finding in cardiac inflammation.
  • This mechanism may contribute to cardiac dysfunction and heart failure in inflammatory metabolic disorders.
  • Targeting PGC-1alpha or related pathways could offer therapeutic strategies for inflammatory cardiomyopathy.
Abstract

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...